Na Tong

3.8k citations

106 papers · 3.1k · h-index 34

Impact in

Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation

Papers in

Molecular Biology 65
- RNA modifications and cancer 17
- Epigenetics and DNA Methylation 15
- Circular RNAs in diseases 13
- RNA Research and Splicing 7
- DNA Repair Mechanisms 6
Cancer Research 40
- MicroRNA in disease regulation 26
- Cancer-related molecular mechanisms research 26

Co-authors: Meilin Wang (67 shared papers)Haiyan Chu (44 shared papers)Zhengdong Zhang (40 shared papers)Zhengdong Zhang (24 shared papers)Mulong Du (20 shared papers)Bin Xu (14 shared papers)Dongying Gu (15 shared papers)Danni Shi (13 shared papers)
Journals: PLoS ONE (9 papers)Bioresource Technology (6 papers)Oncotarget (5 papers)The Prostate (4 papers)Carcinogenesis (4 papers)
Partner nations: China South Korea United States

In The Last Decade

Na Tong

105 papers receiving 3.1k citations

Peers

Countries citing papers authored by Na Tong

Since Specialization

Citations

This map shows the geographic impact of Na Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Tong more than expected).

Fields of papers citing papers by Na Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Tong. The network helps show where Na Tong may publish in the future.

Co-authors

The 25 scholars most cited alongside Na Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Na Tong Line = papers co-authored together Na Tong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo The Prostate ·Bin Xu, Ninghan Feng, Peng‐Chao Li, Jun Tao, Deyao Wu, Zhengdong Zhang, Na Tong, Jinfeng Wang, Ninghong Song, Wei Zhang, Lixin Hua, Hongfei Wu	2009	168
2	MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer The Prostate ·Bin Xu, Ning Wang, Xuhui Wang, Na Tong, Ning Shao, Jun Tao, Pengchao Li, Xiaobing Niu, Ninghan Feng, Lihua Zhang, Lixin Hua, Zengjun Wang, Ming Chen	2011	143
3	Identification of novel piRNAs in bladder cancer Cancer Letters ·Haiyan Chu, Gaoyun Hui, Yuan Lin, Danni Shi, Yubang Wang, Mulong Du, Dongyan Zhong, Lan Ma, Na Tong, Chao Qin, Changjun Yin, Zhengdong Zhang, Meilin Wang	2014	124
4	Genetic variants in lncRNA HOTAIR are associated with risk of colorectal cancer Mutagenesis ·Yao Xue, Dongying Gu, Gaoxiang Ma, Lingjun Zhu, Qiuhan Hua, Haiyan Chu, Na Tong, Jinfei Chen, Zhengdong Zhang, Meilin Wang	2014	123
5	The association analysis of lncRNAHOTAIRgenetic variants and gastric cancer risk in a Chinese population Oncotarget ·Mulong Du, Weizhi Wang, Hua Jin, Qiaoyan Wang, Yuqiu Ge, Jiafei Lu, Gaoxiang Ma, Haiyan Chu, Na Tong, Haixia Zhu, Meilin Wang, Fulin Qiang, Zhengdong Zhang	2015	102
6	A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression The Prostate ·Bin Xu, Jinfeng Wang, Na Tong, Yuanyuan Mi, Zhi-Chao Min, Jun Tao, Pengchao Li, Gong Cheng, Jiuming Li, Meilin Wang, Jialin Tang, Ninghong Song, Zhengdong Zhang, Wei Zhang, Hongfei Wu, Lixin Hua, Ninghan Feng	2010	96
7	Genetic Variants in miRNAs Predict Bladder Cancer Risk and Recurrence Cancer Research ·Meilin Wang, Haiyan Chu, Pu Li, Lin Yuan, Guangbo Fu, Lan Ma, Danni Shi, Dongyan Zhong, Na Tong, Chao Qin, Changjun Yin, Zhengdong Zhang	2012	73
8	Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1 The Prostate ·Bin Xu, Yeqing Huang, Xiaobing Niu, Tao Tao, Liang Jiang, Na Tong, Shuqiu Chen, Ning Liu, Weidong Zhu, Ming Chen	2015	71
9	A Functional Polymorphism in miRNA-196a2 Is Associated with Colorectal Cancer Risk in a Chinese Population DNA and Cell Biology ·Lingjun Zhu, Haiyan Chu, Dongying Gu, Lan Ma, Danni Shi, Dongyan Zhong, Na Tong, Zhengdong Zhang, Meilin Wang	2011	63
10	P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies Breast Cancer Research and Treatment ·Zhizhong Zhang, Meilin Wang, Dongmei Wu, Miaomiao Wang, Na Tong, Yuanyuan Tian, Zhengdong Zhang	2009	59
11	Genetic variants in noncoding PIWI‐interacting RNA and colorectal cancer risk Cancer ·Haiyan Chu, Liping Xia, Xiaonan Qiu, Dongying Gu, Linjun Zhu, Jing Jin, Gaoyun Hui, Qiuhan Hua, Mulong Du, Na Tong, Jinfei Chen, Zhengdong Zhang, Meilin Wang	2015	58
12	Genome-wide analysis of long noncoding RNA signature in human colorectal cancer Gene ·Yao Xue, Gaoxiang Ma, Dongying Gu, Lingjun Zhu, Qiuhan Hua, Mulong Du, Haiyan Chu, Na Tong, Jinfei Chen, Zhengdong Zhang, Meilin Wang	2014	57
13	A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population Archives of Toxicology ·Lan Ma, Lingjun Zhu, Dongying Gu, Haiyan Chu, Na Tong, Jinfei Chen, Zhengdong Zhang, Meilin Wang	2013	56
14	Hsa-miR-196a2 Rs11614913 Polymorphism Contributes to Cancer Susceptibility: Evidence from 15 Case-Control Studies PLoS ONE ·Haiyan Chu, Meilin Wang, Danni Shi, Lan Ma, Zhizhong Zhang, Na Tong, Xinying Huo, Wei Wang, Dewei Luo, Yan Gao, Zhengdong Zhang	2011	55
15	Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients Carcinogenesis ·Mulong Du, Sang Liu, Dongying Gu, Qiaoyan Wang, Lingjun Zhu, Meiyun Kang, Danni Shi, Haiyan Chu, Na Tong, Jinfei Chen, Tamara S. Adams, Zhengdong Zhang, Meilin Wang	2014	54
16	Degradation of 2,4,6-trichlorophenol and determination of bacterial community structure by micro-electrical stimulation with or without external organic carbon source Bioresource Technology ·Hao Xu, Na Tong, Shaobin Huang, Shaofeng Zhou, Shuang Li, Jianjun Li, Yongqing Zhang	2018	53
17	miR-107 regulates tumor progression by targeting NF1 in gastric cancer Scientific Reports ·Shizhi Wang, Gaoxiang Ma, Haixia Zhu, Chunye Lv, Haiyan Chu, Na Tong, Dongmei Wu, Fulin Qiang, Weida Gong, Qinghong Zhao, Guoquan Tao, Jianwei Zhou, Zhengdong Zhang, Meilin Wang	2016	52
18	A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer Oncotarget ·Yao Xue, Gaoxiang Ma, Zhensheng Zhang, Qiuhan Hua, Haiyan Chu, Na Tong, Lin Yuan, Chao Qin, Changjun Yin, Zhengdong Zhang, Meilin Wang	2014	52
19	Association of three polymorphisms in ARID5B, IKZF1and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population Gene ·Yaping Wang, Jing Chen, Jie Li, Jianping Deng, Yaoyao Rui, Qin Lu, Meilin Wang, Na Tong, Zhengdong Zhang, Yongjun Fang	2013	46
20	Genetic Variation in DROSHA 3’UTR Regulated by hsa-miR-27b Is Associated with Bladder Cancer Risk PLoS ONE ·Yuan Lin, Haiyan Chu, Meilin Wang, Xiaojian Gu, Danni Shi, Lan Ma, Dongyan Zhong, Mulong Du, Pu Li, Na Tong, Guangbo Fu, Chao Qin, Changjun Yin, Zhengdong Zhang	2013	44

About Na Tong

Na Tong is a scholar working on Molecular Biology, Cancer Research, Public Health, Environmental and Occupational Health, Oncology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 3.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (26 papers), Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (17 papers), Epigenetics and DNA Methylation (15 papers), Circular RNAs in diseases (13 papers), Acute Lymphoblastic Leukemia research (13 papers), RNA Research and Splicing (7 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.1k citations), Oncology (306 citations), Pathology and Forensic Medicine (158 citations) and Pollution (91 citations). Na Tong has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Meilin Wang, Haiyan Chu, Zhengdong Zhang, Zhengdong Zhang, Mulong Du, Bin Xu, Dongying Gu, Danni Shi, Lan Ma and Dongyan Zhong. Their work appears in journals such as PLoS ONE, Bioresource Technology, Oncotarget, The Prostate and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Na Tong

Impact in

Papers in i

In The Last Decade

Na Tong

Peers

Countries citing papers authored by Na Tong

Fields of papers citing papers by Na Tong

All Works

About Na Tong

Explore authors with similar magnitude of impact

Papers in